Solopharm is a Russian pharmaceutical company producing medicines, medical devices and dietary supplements.

Company history

July 2011

Start of the plant construction and laying of the foundation

March 2013

Completion of the construction and a start of an office work

June 2014

Launch of the 1st stage. The first series of infusion solutions are released

July 2015

Launch of the 2nd stage. Production of ophthalmic and nasal products in multidose form

April 2017

Launch of the 3rd stage - 10 new lines. The GMP certificate is received

April 2019

Solopharm becomes the fastest growing company for the second year in a row. «Platinum Ounce», the prestigious pharmaceutical award is received

May 2019

ISO 13485:2016 certificate for the export of medical devices is received

July 2020

Launch of the biotechnological developments’ laboratory

September 2020

Foundation for solid dosage forms plant is laid.
Solopharm is included in TOP-20 of pharmaceutical companies according to Forbes magazine

February 2021

Solopharm is in Top-10 of the most rapidly developing companies in retail segment by the end of 2020

July 2021

Solopharm receives the EAEU GMP Certificate

September 2021

Solopharm is ranked #16 on the Forbes’ 2021 list of best domestic drug manufacturers

January 2022

Solopharm launches a new manufacturing site for dietary supplements

April 2022

The plant for production of solid dosage forms is opened

June 2022

Confirmation of the Solopharm medical device quality management system to the ISO 13485: 2016 requirements

October 2022

Solopharm entered the TOP-10 in the «Made in St. Petersburg and Leningrad region» nomination, «Fontanka.ru - Recognition and Influence» award

December 2022

Solopharm is ranked #1 in terms of online sales growth rate (according to AlphaRM for 11M-2022)

April 2023

Launch of the 4th stage of the liquid dosage forms production. Increasing the manufacturing facilities of existing and new drugs production, incl. new release forms

April 2023

Launch of the 2nd stage of the dietary supplements plant. Production of dietary supplements in capsules

May 2023

Launch of the plant for design, production, and installation of clean rooms

June 2023

Groundbreaking of the Hormones plant (production of hormonal drugs)

October 2023

Solopharm entered again the TOP-10 in the «Made in St. Petersburg and Leningrad region» and «Employer of the year» nominations, «Fontanka.ru - Recognition and Influence» awards

#16th place on the Forbes’ list as one the best Russian pharmaceutical companies (according to the Forbes rating, September 2021)

TOP-5 Russian manufacturers in terms of sales growth rates (according to the AlphaRM results, September 2022)

2-time winner of the «Platinum Ounce» pharmaceutical award. Category: «Dynamics of the Year»

#1 product on the osteoarthritis treatment market – Armaviscon

CPhI Awards nominee 2018. Category: «Excellence in Pharma: OTC»

TOP-6 of the fastest growing pharmaceutical companies: annual growth rate is 42% (AlphaRM, September 2022)

Angidak is the winner of the «Green Cross» award. «The drug of choice for the sore throat treatment», August 2022

Mestamidin-nasal is the most successful launch in 2021-2022 (according to the Ipsos results, September 2022)

TOP-10 nominee in the «Made in St. Petersburg and Leningrad region» and «Employer of the year» categories, «Fontanka.ru - Recognition and Influence» awards

About Us